Pharmaceutical manufacturer for Molnupiravir

SMS Lifesciences India Limited, headquartered in Hyderabad, India, is a research-driven company with over three decades of experience. It is a public listed leading API manufacturer, supplying to major generic and innovator firms. With a focus on APIs, the company operates four state-of-the-art facilities and provides quality alternative manufacturing solutions to multinational companies for their contract research and manufacturing needs. The company has multiple manufacturing facilities supporting a wide range and capacity of APIs and Intermediates.

BrightGene Bio-Medical Technology Co., Ltd (stock code: 688166) is an innovative pharmaceutical enterprise participating in international competition. Relying on R&D drive, the company focuses on the first imitation, difficult imitation, characteristic APIs, complex preparations and original new drugs, continues to create high-tech barriers, gradually establishes a business system that integrates APIs and preparations, combines generic drugs with innovative drugs, and pays equal attention to the international market and domestic market, and is committed to meeting the unmet clinical needs of patients worldwide.

Aurore Life Sciences is a specialized manufacturer of active pharmaceutical ingredients (API) with a varied range of capabilities to enhance efficiency for generic pharmaceutical companies worldwide. Established in 2017 by a team with extensive expertise throughout the pharmaceutical supply chain, the company is dedicated to becoming the most favored partner for pharmaceuticals. At Aurore, we strive to innovate in the production and delivery of dependable high-quality products, earning the trust of both customers and regulatory bodies. Our focus on rapidly expanding capabilities has driven us to acquire, integrate, and extend our presence across multiple regions.

Ami Lifesciences, established in 2006, is one of the fastest growing Active Pharmaceutical Ingredient (API) manufacturing companies in India, meeting unmet patient needs in various therapeutic areas such as Cardiovascular, Anti-Diabetics, CNS, and Respiratory amongst other categories, produced From Manufacturing unit located in Vadodara, Gujarat. We are recognised as a reliable supplier of generic APIs and a trustworthy Contract Development & Manufacturing partner for generic, Big Pharma & innovator pharmaceutical companies worldwide. We are among the leading manufacturers of APIs, intermediates and registered Key Starting Materials offering quality products with highest quality compliance & integrity to over 60+ countries. We believe, unlocking early launch opportunities, being cost competitive by virtue of backward integration and offering complete supply chain assurance is key to enable our customers to succeed & sustain their products through the product life cycle over a period of time.

Biophore, founded in 2007, has established itself as a dependable partner in the development and production of unique and intricate pharmaceutical products. With 4 USFDA and EU-certified API manufacturing facilities, a specialized intermediate facility, and a research and development laboratory accommodating 400 scientists, Biophore has positioned itself as a worldwide leader among API companies. It consistently ranks among the top 10 US DMF submitters and has acquired over 150 patents globally in process and polymorph areas. Biophore's facilities have an impressive history of successful inspections by regulatory authorities such as USFDA, EMEA, ANVISA, COFEPRIS, and WHO GMP.

Honour Lab Limited is based in India. The corporation's primary activity involves the production, crafting, or refinement of medications in pharmaceutical formulations for human or animal application.

Gonane Pharma, located in the state of Gujarat in India, is a well-established GMP-certified manufacturer and exporter of sterile and non-sterile APIs, specializing in corticosteroids, hormones, antivirals, and oncology products. With over 25 years of experience, the company's promoters have effectively marketed and manufactured products while managing audits for various regulated markets, including the EU, Mexico, China, Korea, and Russia. Gonane Pharma is currently focused on expanding into the Japanese market and other international markets. The company offers a diverse range of high-quality products, including donepezil HCl, donepezil base, albendazole, racecadortril, rosuvastatin calcium, and allopurinol, and remains dedicated to R&D investments for superior products and services.

Kimia Biosciences, established in 1993, specializes in the production of bulk drugs for various medical segments. With a strong focus on quality and advanced technologies, Kimia aims to achieve global recognition in the production of both APIs and FDFs, while maintaining ethical business practices. The state-of-the-art facilities at Village Bhondsi, Gurugram enable the production of a wide range of APIs. Additionally, Kimia plans to develop its own facilities for lifestyle segments, adhering to international regulatory standards, with the goal of delivering top-quality pharmaceutical products and support to both consumers and healthcare professionals.

Founded in 1993, the company specialized in manufacturing API’s and Intermediates with its manufacturing facility in Sadasivpet, Hyderabad (50 km from Rajiv Gandhi International Airport). In 1995, the company became a public listed company and was listed on the BSE. Everest Organics Limited is headed by seasoned professionals who have strong expertise in the field of medical science, marketing and business administration.

Zhejiang nisikang Pharmaceutical Co., Ltd. was established in December 2002, with advanced manufacturing equipment and technology. The production plant is located in Linjiang Industrial Zone, Wucheng District, Jinhua City, Zhejiang Province, covering an area of 338 mu (252012 square meters). The registered capital of the company is 370 million yuan. It is a modern manufacturing enterprise mainly engaged in R & D, production and sales of APIs.

Since established in 2000, Suzhou Lixin Pharmaceutical Co., Ltd. has been aimed at developing the global normative dominant market of characteristic APIs and advanced intermediates, driven by technological innovation, taken the path of sustainable development, and gradually formed the pharmaceutical product lines including anti-tumor, cardiovascular, antiviral and digestive system and other areas. Lixin has already become the high-quality supplier of many global pharmaceutical companies and has established the long-term relationship with a number of well-known domestic and foreign pharmaceutical companies to achieve win-win cooperation.

Established in 2003, a prominent producer of advanced intermediates and APIs in the pharmaceutical sector. Providing manufacturing services and ensuring high quality for the worldwide pharmaceutical market. Holds over 20 GMP licenses and has been approved by USFDA, PMDA, and MFDS. Achieves an annual sales turnover of approximately USD130,000,000.